<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197339</url>
  </required_header>
  <id_info>
    <org_study_id>DC008290</org_study_id>
    <secondary_id>5R01DC008290</secondary_id>
    <nct_id>NCT01197339</nct_id>
  </id_info>
  <brief_title>Hybrid Model of Vocal Inflammation and Tissue Mobilization</brief_title>
  <official_title>Hybrid Model of Vocal Inflammation and Tissue Mobilization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to generate a technology that will allow clinicians to prescribe
      behavioral treatment that should optimize tissue healing for both acute and chronic
      phonotrauma. In this study, we propose to (1): establish a non-invasive methodology for
      estimating overall mechanical dose during phonation, and component metrics of phonatory
      mechanical dose (e.g., distance dose, energy dissipation dose and time dose) from high speed
      imaging data and aeromechanical modeling, for a range of vocal fold configurations
      (Experiment 1); (2): identify mathematical relations between treatment dose parameters,
      inflammatory state of the tissue and time-varying biological consequences in the tissue, up
      to 2 wk following acute phonotrauma (Experiment 2); (3): develop a hybrid physical-biological
      model of vocal fold inflammation and treatment to identify treatment modalities that should
      optimize post-traumatic wound healing at 2 wk, for a range of acute phonotraumatic conditions
      (Experiment 3â€”no human subject involved), and (4): provide a preliminary test of the hybrid
      treatment models' ability to predict idealized treatment outcome in human subjects, and
      calibrate the model as needed iteratively to achieve a match between predicted and obtained
      outcomes (Experiment 4).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker levels in laryngeal secretion</measure>
    <time_frame>up to 2 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Acute Phonotrauma</condition>
  <arm_group>
    <arm_group_label>treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>resonant voice</intervention_name>
    <description>A 4-hr resonant voice exercise will be prescribed to subjects following vocal loading.</description>
    <arm_group_label>treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>voice rest</intervention_name>
    <description>A 4-hr voice rest will be prescribed to subjects following vocal loading.</description>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Breathy voice</intervention_name>
    <description>A 4-hr breathy voice exercise will be prescribed to subjects following vocal loading.</description>
    <arm_group_label>treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relaxation exercise</intervention_name>
    <description>A 4-hr relaxation exercise will be prescribed to subjects following vocal loading.</description>
    <arm_group_label>treatment</arm_group_label>
    <other_name>meditation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resonant voice and relaxation exercise</intervention_name>
    <description>A 4-hr resonant voice and relaxation exercise will be prescribed to subjects following vocal loading.</description>
    <arm_group_label>treatment</arm_group_label>
    <other_name>Resonant voice and meditation exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy females

          -  ages 18-40

          -  generally healthy

          -  normal hearing bilaterally at 20 dB to 8,000 Hz

          -  have ability to produce &quot;resonant voice&quot; during training as determined by the examiner
             perceptually

          -  Tolerate rigid and nasal endoscopy without anesthesia to the larynx nasal patency
             allowing for the passage of an endoscope unilaterally

        Exclusion Criteria:

          -  Smoking within the past five yr

          -  Failing a hearing screening test

          -  Having current chronic voice problems

          -  Having current medications that are determined to possibly influence voice

          -  Having heightened gag reflex

          -  Having known or suspected allergy to anesthetics

          -  Pregnancy reported
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Verdolini Abbott, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univesity of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Li NY, Abbott KV, Rosen C, An G, Hebda PA, Vodovotz Y. Translational systems biology and voice pathophysiology. Laryngoscope. 2010 Mar;120(3):511-5. doi: 10.1002/lary.20755. Review.</citation>
    <PMID>20025041</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2010</study_first_submitted>
  <study_first_submitted_qc>September 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>January 21, 2016</last_update_submitted>
  <last_update_submitted_qc>January 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Kittie Verdolini Abbott</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>acute phonotrauma</keyword>
  <keyword>computer modeling</keyword>
  <keyword>resonant voice</keyword>
  <keyword>breathy voice</keyword>
  <keyword>voice rest</keyword>
  <keyword>relaxation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

